Rohit Ramchandani - 21 Oct 2025 Form 4 Insider Report for Performant Healthcare Inc (PHLT)

Role: Chief Financial Officer
Signature: /s/ Rohit Ramchandani
Issuer symbol: PHLT
Transactions as of: 21 Oct 2025
Net transactions value: -$3,537,356
Form type: 4
Filing time: 21 Oct 2025, 12:06:55 UTC
Previous filing: 20 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ramchandani Rohit	Chief Financial Officer	900 SOUTH PINE ISLAND ROAD, SUITE 150, PLANTATION	/s/ Rohit Ramchandani	21 Oct 2025	0001976990

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHLT	Common Stock, par value $0.0001 per share	Disposed to Issuer		-299,101	-100%		0	21 Oct 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHLT	Restricted Stock Units	Disposed to Issuer	$179,506	-23,162	-100%	$7.75	0	21 Oct 2025	Common Stock	23,162	$0.000000	Direct	F3, F4
transaction	PHLT	Restricted Stock Units	Disposed to Issuer	$419,903	-54,181	-100%	$7.75	0	21 Oct 2025	Common Stock	54,181	$0.000000	Direct	F4, F5
transaction	PHLT	Restricted Stock Units	Disposed to Issuer	$419,895	-54,180	-100%	$7.75	0	21 Oct 2025	Common Stock	54,180	$0.000000	Direct	F3, F4
transaction	PHLT	Restricted Stock Units	Disposed to Issuer	$304,854	-39,336	-100%	$7.75	0	21 Oct 2025	Common Stock	39,336	$0.000000	Direct	F3, F4
transaction	PHLT	Restricted Stock Units	Disposed to Issuer	$337,815	-43,589	-100%	$7.75	0	21 Oct 2025	Common Stock	43,589	$0.000000	Direct	F4, F5
transaction	PHLT	Restricted Stock Units	Disposed to Issuer	$378,138	-48,792	-100%	$7.75	0	21 Oct 2025	Common Stock	48,792	$0.000000	Direct	F3, F4
transaction	PHLT	Restricted Stock Units	Disposed to Issuer	$709,877	-91,597	-100%	$7.75	0	21 Oct 2025	Common Stock	91,597	$0.000000	Direct	F3, F4
transaction	PHLT	Restricted Stock Units	Disposed to Issuer	$709,869	-91,596	-100%	$7.75	0	21 Oct 2025	Common Stock	91,596	$0.000000	Direct	F4, F5
transaction	PHLT	Non-Qualified Stock Options	Disposed to Issuer	$77,500	-10,000	-100%	$7.75	0	21 Oct 2025	Common Stock	10,000	$1.74	Direct	F4, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Rohit Ramchandani is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger").
F2	Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement.
F3	Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.
F4	All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date.
F5	Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to performance-based vesting conditions, that is outstanding immediately prior to the Effective Time (each, a "Performant PRSU") (i) to the extent not vested, shall be deemed to have satisfied such vesting conditions at 100% of target and shall have any time-based vesting conditions waived and (ii) will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (A) the number of Company Shares underlying such Performant PRSU multiplied by (B) the Merger Consideration.
F6	Effective immediately prior to the Effective Time, each option to purchase Company Shares, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant Stock Option") will automatically be canceled and converted into the right to receive (without interest) an amount in cash (less applicable withholding taxes) equal to the product of (i) the aggregate number of Company Shares underlying such Performant Stock Option multiplied by (ii) the excess, if any, of the Merger Consideration over the per share exercise price of such Performant Stock Option.